Characteristics of lymphocyte phenotypes in HBV transgenic mice and the effect of interferon-α: a preliminary study.
- Author:
	        		
		        		
		        		
			        		Xin YAN
			        		
			        		
			        		
			        			1
			        			,
			        		
			        			2
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Rui-Hua ZHONG
			        		
			        		;
		        		
		        		
		        		
			        		Jin-Hong LIU
			        		
			        		;
		        		
		        		
		        		
			        		Yang ZHOU
			        		
			        		;
		        		
		        		
		        		
			        		Li-Bo TANG
			        		
			        		;
		        		
		        		
		        		
			        		Yong-Yin LI
			        		
			        		;
		        		
		        		
		        		
			        		Guang-Ze LIU
			        		
			        		;
		        		
		        		
		        		
			        		Jin-Lin HOU
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Journal Article
 - MeSH: Animals; Antiviral Agents; pharmacology; B-Lymphocytes; drug effects; DNA, Viral; blood; Hepatitis B; drug therapy; immunology; Hepatitis B Antibodies; blood; Hepatitis B Surface Antigens; blood; Hepatitis B virus; Interferon-alpha; pharmacology; Interleukin-6; blood; Interleukins; blood; Liver; immunology; Lymphocyte Subsets; cytology; drug effects; Mice; Mice, Transgenic; Phenotype; T-Lymphocytes; drug effects
 - From: Journal of Southern Medical University 2016;36(6):870-874
 - CountryChina
 - Language:Chinese
 - 
		        	Abstract:
			       	
			       		
				        
				        	
OBJECTIVETo analyze the characteristics of lymphocyte phenotypes in hepatitis B virus (HBV) transgenic mice and the effect of exogenous interferon-α on virological profiles and lymphocytes phenotypes of the mice.
METHODSHBV transgenic mice and wild-type (WT) mice were examined for serum levels of HBsAg, HBcAb, IL-21, and IL-6 using ELISA. The frequencies of CD4(+)T and CD19(+)B cells separated from the liver, spleen, and peripheral blood were detected by flow cytometry. Nine HBV transgenic mice were injected subcutaneously with recombinant mouse interferon alpha (rmIFN-α) and another 9 transgenic mice were injected with PBS, and their HBsAg, HBV DNA, IL-6, and IL-21 levels and frequencies of peripheral blood CD4(+)T and CD19(+)B cells were detected.
RESULTSHBV transgenic mice showed a high level of HBsAg with a detectable level of HBcAb and significantly increased serum levels of IL-21 and IL-6 as compared with WT mice (P<0.05). The transgenic mice had a significantly lower frequency of CD4(+) T cells in the peripheral blood, liver and spleen (P<0.05) but a significantly higher frequency of CD19(+) B cells in the liver (P<0.05). An inverse correlation between intrahepatic CD4(+) T cell frequency and serum HBsAg level while a positive correlation between intrahepatic CD19(+) B cell frequency and HBcAb level were found in HBV transgenic mice. Administration of rmIFN-α significantly increased the frequencies of CD4(+) T and CD19(+) B cells in the peripheral blood and the serum level of IL-6 in HBV transgenic mice (P<0.05).
CONCLUSIONHBV transgenic mice have lymphocyte subset dysregulation and exogenous interferon-α can modulate the immune function of the mice by regulating the frequencies of lymphocyte subsets.
 
            